Influx Healthtech (NSE:INFLUX) EPS (Basic): ₹9.35 (TTM As of Mar. 2026)


NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
21 GF Score
Price ₹285.35
! 3 Warning Signs
View Full Analysis

What is Influx Healthtech EPS (Basic)?

Influx Healthtech NSE:INFLUX +9.62% 21 EPS (Basic) is ₹9.35 as of Mar. 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Influx Healthtech's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹4.54. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.35.

Influx Healthtech's EPS (Diluted) for the six months ended in Mar. 2026 was ₹4.54. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.35.

Influx Healthtech's EPS without NRI for the six months ended in Mar. 2026 was ₹4.54. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 9.35.

During the past 12 months, Influx Healthtech's average EPS without NRIGrowth Rate was 61.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 44.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Influx Healthtech's highest 3-Year average EPS without NRI Growth Rate was 44.30% per year. The lowest was 43.80% per year. And the median was 44.05% per year.

Influx Healthtech  (NSE:INFLUX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Influx Healthtech EPS (Basic) Related Terms

Influx Healthtech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech EPS (Basic) Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
1.95 3.11 4.81 5.77 9.35

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.00 2.43 3.35 4.81 4.54
NSE:INFLUX
21GF Score
Influx Healthtech Ltd NSE:INFLUX
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Influx Healthtech's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(205.387-0)/21.967
=9.35

Influx Healthtech's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(105.259-0)/23.116
=4.55

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹9.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹9.35 mean?
Influx Healthtech (NSE:INFLUX) has a EPS (Basic) of ₹9.35 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Influx Healthtech and its competitors.
Is Influx Healthtech's EPS (Basic) too high?
Influx Healthtech's current EPS (Basic) is ₹9.35. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's EPS (Basic) compare to ZTS?
Influx Healthtech's EPS (Basic) of ₹9.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Influx Healthtech and its competitors. Influx Healthtech's current EPS (Basic) is ₹9.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current EPS (Basic) of ₹9.35. The current EPS (Basic) is ₹9.35. Influx Healthtech's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current EPS (Basic) is ₹9.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score

Get the complete analysis for NSE:INFLUX

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹285.35
Price